Clinical Trial Update: Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating epcoritamab for patients with follicular lymphoma who did not achieve a complete response to upfront chemoimmunotherapy; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Epcoritamab (epcoritamab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Lymphoma, Follicular Lymphoma | Phase 2 | Status: RECRUITING